Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun;18(6):642-7.
doi: 10.1038/ejhg.2009.242. Epub 2010 Jan 20.

Genotype-phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I

Affiliations

Genotype-phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type I

Frank Rauch et al. Eur J Hum Genet. 2010 Jun.

Abstract

Osteogenesis imperfecta (OI) is a heritable disorder with bone fragility that is often associated with short stature, tooth abnormalities (dentinogenesis imperfecta), and blue sclera. The most common mutations associated with OI result from the substitution for glycine by another amino acid in the triple helical domain of either the alpha1 or the alpha2 chain of collagen type I. In this study, we compared the results of genotype analysis and clinical examination in 161 OI patients (median age: 13 years) who had glycine mutations in the triple helical domain of alpha1(I) (n=67) or alpha2(I) (n=94). Serine substitutions were the most frequently encountered type of mutation in both chains. Compared with patients with serine substitutions in alpha2(I) (n=40), patients with serine substitutions in alpha1(I) (n=42) on average were shorter (median height z-score -6.0 vs -3.4; P=0.005), indicating that alpha1(I) mutations cause a more severe phenotype. Height correlated with the location of the mutation in the alpha2(I) chain but not in the alpha1(I) chain. Patients with mutations affecting the first 120 amino acids at the amino-terminal end of the collagen type I triple helix had blue sclera but did not have dentinogenesis imperfecta. Among patients from different families sharing the same mutation, about 90 and 75% were concordant for dentinogenesis imperfecta and blue sclera, respectively. These data should be useful to predict disease phenotype in newly diagnosed OI patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationship between the triple helical position of glycine mutations in collagen type I α chains and the presence (+) or absence (−) of deformities or fractures at birth (DFB), blue sclera (BS), and dentinogenesis imperfecta (DI).
Figure 2
Figure 2
Relationship between the positions of glycine substitutions in the triple helical domain of type I collagen and height z-scores. The oblique solid lines represent the regression lines between the position of serine substitutions in α2(I) and height (r=−0.73, P<0.001; Spearman's rank correlation). The oblique dashed line represents the regression line between the position of aspartate substitutions in α2(I) and height (r=−0.75, P<0.001).

Similar articles

Cited by

References

    1. Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet. 2004;363:1377–1385. - PubMed
    1. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16:101–116. - PMC - PubMed
    1. Dalgleish R. The human type I collagen mutation database. Nucleic Acids Res. 1997;25:181–187. - PMC - PubMed
    1. Dalgleish R. The human collagen mutation database 1998. Nucleic Acids Res. 1998;26:253–255. - PMC - PubMed
    1. Marini JC, Forlino A, Cabral WA, et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat. 2007;28:209–221. - PMC - PubMed

Publication types